Search: onr:"swepub:oai:DiVA.org:uu-474463" > Intake Patterns of ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 07681naa a2200649 4500 | |
001 | oai:DiVA.org:uu-474463 | |
003 | SwePub | |
008 | 220516s2022 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:149375242 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4744632 URI |
024 | 7 | a https://doi.org/10.3390/cancers140819812 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1493752422 URI |
040 | a (SwePub)uud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Lin, Hui-Yiu Louisiana State Univ, Sch Publ Hlth, Biostat Program, Hlth Sci Ctr, New Orleans, LA 70112 USA.4 aut |
245 | 1 0 | a Intake Patterns of Specific Alcoholic Beverages by Prostate Cancer Status |
264 | c 2022-04-14 | |
264 | 1 | b MDPI AG,c 2022 |
338 | a electronic2 rdacarrier | |
520 | a Simple Summary Previous studies have shown heavy intake of different alcoholic beverages affects prostate cancer (PCa) clinical outcomes differently. However, the intake patterns of specific alcoholic beverages for PCa status are understudied. The study's objective is to evaluate intake patterns of total alcohol and three types of alcoholic beverage (beer, wine, and spirits) by PCa risk and aggressiveness status. This study included 10,029 men with European ancestry (4676 non-PCa men and 5353 PCa patients). We found PCa patients had a similar total heavy alcohol intake compared with non-PCa men. However, PCa patients were likely to drink more wine and spirits than non-PCa men. Patients with aggressive PCa drank more beer but not wine and spirits. Interestingly, heavy wine intake was inversely associated with PCa aggressiveness. These findings suggest that the intake patterns of specific alcoholic beverages differ by PCa status, and this information might help develop personalized alcohol intervention for PCa patients. Background: Previous studies have shown that different alcoholic beverage types impact prostate cancer (PCa) clinical outcomes differently. However, intake patterns of specific alcoholic beverages for PCa status are understudied. The study's objective is to evaluate intake patterns of total alcohol and the three types of beverage (beer, wine, and spirits) by the PCa risk and aggressiveness status. Method: This is a cross-sectional study using 10,029 men (4676 non-PCa men and 5353 PCa patients) with European ancestry from the PCa consortium. Associations between PCa status and alcohol intake patterns (infrequent, light/moderate, and heavy) were tested using multinomial logistic regressions. Results: Intake frequency patterns of total alcohol were similar for non-PCa men and PCa patients after adjusting for demographic and other factors. However, PCa patients were more likely to drink wine (light/moderate, OR = 1.11, p = 0.018) and spirits (light/moderate, OR = 1.14, p = 0.003; and heavy, OR = 1.34, p = 0.04) than non-PCa men. Patients with aggressive PCa drank more beer than patients with non-aggressive PCa (heavy, OR = 1.48, p = 0.013). Interestingly, heavy wine intake was inversely associated with PCa aggressiveness (OR = 0.56, p = 0.009). Conclusions: The intake patterns of some alcoholic beverage types differed by PCa status. Our findings can provide valuable information for developing custom alcohol interventions for PCa patients. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a alcohol | |
653 | a beverage | |
653 | a prostate cancer | |
653 | a aggressiveness | |
700 | 1 | a Tseng, Tung-Sungu Louisiana State Univ, Sch Publ Hlth, Behav & Community Hlth Sci Program, Hlth Sci Ctr, New Orleans, LA 70112 USA.4 aut |
700 | 1 | a Wang, Xinnanu Louisiana State Univ, Sch Publ Hlth, Biostat Program, Hlth Sci Ctr, New Orleans, LA 70112 USA.4 aut |
700 | 1 | a Fang, Zhideu Louisiana State Univ, Sch Publ Hlth, Biostat Program, Hlth Sci Ctr, New Orleans, LA 70112 USA.4 aut |
700 | 1 | a Zea, Arnold H.u Louisiana State Univ, Sch Med, Dept Microbiol, Hlth Sci Ctr, New Orleans, LA 70112 USA.;Louisiana State Univ, Stanley S Scott Canc Ctr, Hlth Sci Ctr, New Orleans, LA 70112 USA.4 aut |
700 | 1 | a Wang, Liangu H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA.4 aut |
700 | 1 | a Pow-Sang, Juliou H Lee Moffitt Canc Ctr & Res Inst, Dept Genitourinary Oncol, Tampa, FL 33612 USA.4 aut |
700 | 1 | a Tangen, Catherine M.u Fred Hutchinson Canc Res Ctr, SWOG Stat Ctr, Seattle, WA 98109 USA.4 aut |
700 | 1 | a Goodman, Phyllis J.u Fred Hutchinson Canc Res Ctr, SWOG Stat Ctr, Seattle, WA 98109 USA.4 aut |
700 | 1 | a Wolk, Alicjau Karolinska Institutet,Uppsala universitet,Ortopedi,Medicinsk epidemiologi4 aut0 (Swepub:uu)alwol516 |
700 | 1 | a Hakansson, Niclasu Karolinska Institutet4 aut |
700 | 1 | a Kogevinas, Manolisu Barcelona Inst Global Hlth ISGlobal, Barcelona 08036, Spain.;IMIM Hosp Mar Med Res Inst, Barcelona 08003, Spain.;Univ Pompeu Fabra UPF, Barcelona 08002, Spain.;CIBER Epidemiol & Salud Publ CIBERESP, Madrid 28029, Spain.4 aut |
700 | 1 | a Llorca, Javieru CIBER Epidemiol & Salud Publ CIBERESP, Madrid 28029, Spain.;Univ Cantabria, Santander 39005, Spain.4 aut |
700 | 1 | a Brenner, Hermannu German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany.;German Canc Res Ctr, German Canc Consortium DKTK, D-69120 Heidelberg, Germany.;German Canc Res Ctr, Div Prevent Oncol, Neuenheimer Feld 460, D-69120 Heidelberg, Germany.;Natl Ctr Tumor Dis NCT, Neuenheimer Feld 460, D-69120 Heidelberg, Germany.4 aut |
700 | 1 | a Schoettker, Benu German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany.4 aut |
700 | 1 | a Esteban Castelao, Joseu Complexo Hosp Univ Vigo, CHUVI Hosp, Inst Invest Biomed Galicia Sur IISGS, Genet Oncol Unit, Vigo 36204, Spain.4 aut |
700 | 1 | a Gago-Dominguez, Manuelau Complejo Hosp Univ Santiago, Galician Fdn Genom Med, Inst Invest Sanitaria Santiago de Compostela IDIS, Serv Galego Saude,SERGAS,Genom Med Grp, Santiago De Compostela 15706, Spain.;Univ Calif San Diego, Moores Canc Ctr, Dept Family Med & Publ Hlth, La Jolla, CA 92037 USA.4 aut |
700 | 1 | a Gamulin, Marijau Univ Hosp Ctr Zagreb, Dept Oncol, Zagreb 10000, Croatia.;Univ Zagreb, Sch Med, Zagreb 10000, Croatia.4 aut |
700 | 1 | a Lessel, Davoru Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany.4 aut |
700 | 1 | a Claessens, Franku Univ Leuven, Dept Cellular & Mol Med, Mol Endocrinol Lab, Campus Gasthuisberg,Herestr 49,POB 901, B-3000 Leuven, Belgium.4 aut |
700 | 1 | a Joniau, Stevenu Univ Hosp Leuven, Dept Urol, Herestr 49,POB 7003 41, B-3000 Leuven, Belgium.4 aut |
700 | 1 | a Park, Jong Y.u H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL 33612 USA.4 aut |
710 | 2 | a Louisiana State Univ, Sch Publ Hlth, Biostat Program, Hlth Sci Ctr, New Orleans, LA 70112 USA.b Louisiana State Univ, Sch Publ Hlth, Behav & Community Hlth Sci Program, Hlth Sci Ctr, New Orleans, LA 70112 USA.4 org |
773 | 0 | t Cancersd : MDPI AGg 14:8q 14:8x 2072-6694 |
856 | 4 | u https://doi.org/10.3390/cancers14081981y Fulltext |
856 | 4 | u https://uu.diva-portal.org/smash/get/diva2:1658299/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-474463 |
856 | 4 8 | u https://doi.org/10.3390/cancers14081981 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:149375242 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.